Metabolic syndrome, independent predictor for coronary artery disease

Clinical Laboratory

Volumn 61, Issue 10, 2015, Pages 1545-1552

  Zidi, Wiem ^a   Allal Elasmi, Monia ^b   Zayani, Yosra ^b   Zaroui, Amira ^b   Guizani, Imen ^b   Feki, Moncef ^b   Mourali, Mohamed Sami ^b   Mechmeche, Rachid ^b   Kaabachi, Naziha ^b  

^a UNIVERSITY OF CARTHAGE   (Tunisia)

^b LA RABTA HOSPITAL   (Tunisia)

Author keywords

Coronary artery disease; Gensini score; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENSINI SCORE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHENOTYPE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; ANGIOGRAPHY; BLOOD; BLOOD PRESSURE; COMPLICATION; ODDS RATIO; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; REGRESSION ANALYSIS; REPRODUCIBILITY; RISK FACTOR; SMOKING;

AGED; ANGIOGRAPHY; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING;

EID: 84948426592     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2015.150219     Document Type: Article

References (39)

1. Prabhakaran D, Anand SS The metabolic syndrome: an emerging risk state for cardiovascular disease. Vase Med 2004; 9:55-68.
2. Girman CJ, Rhodes T, Mercuri M., et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004; 93:136-41.
3. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
4. Allal-Elasmi M., Haj Taieb S, Hsairi M, et al The metabolic syndrome: Prevalence, main characteristics and association with socio-economic status in adults living in Great Tunis. Diabetes Metab 2010; 36:204-8.
5. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51:606.
6. Su G, Mi S, Tao H., et al. Association of glycémie variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2011; 10:19.
7. Reiner ET, Strozzi M, Skoric B., Reiner Z. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol 2005; 96:1107-9.
8. Lekatsas I, Kranidis A, Ioannidis G., et al. Comparison of the extent and severity of coronary artery disease in patients with acute myocardial infarction with and without microalbuminuria. Am J Cardiol 2004; 94:334-7.
9. Tarchalski J, Guzik P, Wysocki H. Correlation between the extent of coronary atherosclerosis and lipid profile. Mol Cell Biochem 2003; 246:25-30.
10. Konstantinou DM, Chatzizisis YS, Louridas G.E., Giannoglou GD. Metabolic syndrome and angiographic coronary artery disease prevalence in association with the Framingham Risk Score. Metab Syndr Relat Disord 2010; 8:201-8.
11. Athyros VG, Ganotakis ES, Elisaf M.S., et al. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol 2007; 117:204-10.
12. Campbell CY, Nasir K, Sarwar A., et al. Combined effect of high low-density lipoprotein cholesterol and metabolic syndrome on sub-clinical coronary atherosclerosis in white men without clinical evidence of myocardial ischemia. Am J Cardiol 2007; 100: 840-3.
13. Solymoss BC, Bourassa MG, Campeau L, et al Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 93:159-64.
14. Kim JY, Mun HS, Lee B.K., et al. Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease. Yonsei Med J 2010; 51:67682.
15. Yavuz B, Kabakci G, Aksoy H., et al. Determining the relationship between metabolic syndrome score and angiographic severity of coronary artery disease. Int J Clin Pract 2008; 62:717-22.
16. Romm PA, Green CE, Reagan K, Rackley CE Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol 1991; 67:479-83.
17. Jenkins PJ, Harper RW, Nestel PJ Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J 1978; 2: 388-91.
18. Rye KA, Bursill CA, Lambert G, Tabet F., Barter PJ. The metabolism and anti-atherogenic properties of HDL. J Lipid Res 2009; 50 Suppl: S 195-200.
19. Feig JE, Shamir R, Fisher EA Atheroprotective effects of HDL: beyond reverse cholesterol transport. Curr Drug Targets 2008; 9: 196-203.
20. Thompson GR. The proving of the lipid hypothesis. Curr Opin Lipidol 1999; 10:201-5.
21. Iribarren C. The metabolic syndrome is no better than its components. Minerva Cardioangiol 2007; 55:487-9.
22. Wang J, Ruotsalainen S, Moilanen L., Lepistö P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007; 28:857-64.
23. Amano T, Matsubara T, Uetani T., et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions. J Am Coll Cardiol 2007; 49:1149-56.
24. Bayturan O, Tuzcu EM, Lavoie A, et al The metabolic syndrome, its component risk factors and progression of coronary atherosclerosis. Arch Intern Med 2010; 170:478-84.
25. Maron DJ, Boden WE, Spertus J.A., et al. Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary interventions in the COURAGE trial. J Am Coll Cardiol 2011; 58:131-7.
26. Ertek S, Cicero AF, Cesur M, et al The severity of coronary atherosclerosis in diabetic and non-diabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography. Acta Diabetol 2011; 48:21-7.
27. Kwon K, Choi D, Koo B.K., Ryu SK. Decreased insulin sensitivity is associated with the extent of coronary artery disease in patients with angina. Diabetes Obes Metab 2005; 7:579-85.
28. Timóteo A.T., Mota Carmo M, Cruz Ferreira R. Does metabolic syndrome predict significant angiographic coronary artery disease? Rev Port Cardiol 2012; 31:769-78.
29. Yoon SE, Ahn SG, Kim J.Y., et al. Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population. J Korean Med Sci 2011; 26:900-5.
30. Eckel RH, Grundy SM, Zimmet PZ The metabolic syndrome. Lancet 2005; 365:1415-28.
31. Hong Y, Jin X, Mo J., et al. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality: results of prospective analysis for the Atherosclerosis Risk in Communities study. J Intern Med 2007; 262:113-22.
32. Isomaa B, Almgren P, Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683-9.
33. Dortimer AC, Shenoy PN, Shiroff R.A., et al. Diffuse coronary artery disease in diabetic patients: fact or fiction? Circulation 1978; 57:133-6.
34. Vigorito C, Betocchi S, Bonzani G., et al. Severity of coronary artery disease in patients with diabetes mellitus. Angiographic study of 34 diabetic and 120 nondiabetic patients. Am Heart J 1980; 100:782-7.
35. Zornitzki T, Ayzenberg O, Gandelman G., et al. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women. QJM 2007; 100:575-81.
36. Kasaoka S, Okuda F, Satoh A., et al. Effect of coronary risk factors on coronary angiographic morphology in patients with ischemic heart disease. Jpn Circ J 1997; 61:390-5.
37. Bonora E, Targher G, Formentini G., et al. The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 2004; 21:52-8.
38. Meigs JB, Wilson PW, Fox C.S., et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91:2906-12.
39. McLaughlin T, Abbasi F, Lamendola C., Reaven G. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 2007; 167:642-8.